Company Overview of Anadys Pharmaceuticals Inc.
Key Executives for Anadys Pharmaceuticals Inc.
|James Appleman Ph.D.||15 Relationships||Chief Scientific Officer and Senior Vice President of Research||59|
|Devron R. Averett Ph.D.||9 Relationships||Chief Scientific Counsel and Member of Clinical & Scientific Advisory Board||66|
|Vince Reardon||No Relationships||Senior Director of Investor Relations & Corporate Communications||--|
|Kevin L. Eastwood||No Relationships||Senior Vice President of Corporate Development||52|
Anadys Pharmaceuticals Inc. Board Members*
|Name||Board Relationships||Primary Company||Age|
|Devron R. Averett Ph.D.||9 Relationships||Anadys Pharmaceuticals Inc.||66|
|Douglas D. Richman M.D.||88 Relationships||Chimerix, Inc.||--|
|Jason S. Fisherman M.D., MBA||55 Relationships||Synthesis Capital||59|
|K. C. Nicolaou Ph.D.||47 Relationships||CytomX Therapeutics, Inc.||--|
|John G. McHutchison M.D., FRACP||30 Relationships||Gilead Sciences Inc.||--|
Anadys Pharmaceuticals Inc. Executive Committees*
|Committee Name||Chairperson||Board Relationships||Members|
|Advisory Board M.D.||Douglas D. Richman||88 Relationships||8 Executives|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
CEO COMPENSATION IN THIS INDUSTRY
|Total Short Term Compensation|
|Total Value of Options|